InvestorsHub Logo
Followers 4
Posts 316
Boards Moderated 0
Alias Born 06/29/2021

Re: None

Saturday, 09/30/2023 10:35:52 AM

Saturday, September 30, 2023 10:35:52 AM

Post# of 462234
6 months ago

ANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in Long-Term 48Week Phase 2 Extension Study in PDD

Where is P3 ? Or even better NDA ?

https://www.anavex.com/post/anavex-2-73-blarcamesine-shows-clinical-benefit-in-long-term-48week-phase-2-extension-study-in-pdd
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News